Related references
Note: Only part of the references are listed.Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study
Marten A. Lantinga et al.
DRUG SAFETY (2017)
Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial
Olivier Devuyst et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Ciliopathies
Daniela A. Braun et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Isolated polycystic liver disease genes define effectors of polycystin-1 function
Whitney Besse et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Polycystic Kidney Disease without an Apparent Family History
Ioan-Andrei Iliuta et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Novel treatment protocol for ameliorating refractory, chronic pain in patients with autosomal dominant polycystic kidney disease
Niek F. Casteleijn et al.
KIDNEY INTERNATIONAL (2017)
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease
Vicente E. Torres et al.
KIDNEY INTERNATIONAL (2017)
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
Sachin Hajarnis et al.
NATURE COMMUNICATIONS (2017)
Dietary protein intake and chronic kidney disease
Gang Jee Ko et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2017)
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Ronald D. Perrone et al.
KIDNEY INTERNATIONAL REPORTS (2017)
Therapeutic microRNAs in polycystic kidney disease
Matanel Yheskel et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)
Precision Medicine for Hypertension Management in Chronic Kidney Disease: Relevance of SPRINT for Therapeutic Targets in Nondiabetic Renal Disease
Marcel Ruzicka et al.
CANADIAN JOURNAL OF CARDIOLOGY (2017)
Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment
Dario Turco et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014)
Mangalee R. Fernando et al.
POPULATION HEALTH METRICS (2017)
Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial
Niek F. Casteleijn et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
LRP5 variants may contribute to ADPKD
Wybrich R. Cnossen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease
Young-Hwan Hwang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease
Emilie Cornec-Le Gall et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease
Ladan Zand et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial
Ron T. Gansevoort et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience
Stefan Zschiedrich et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Spot urine sodium measurements do not accurately estimate dietary sodium intake in chronic kidney disease
Carly E. Dougher et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Mutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease
Binu Porath et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial
Vicente E. Torres et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease
Youngwoo Kim et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4
Piero Ruggenenti et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Copeptin levels and kidney function in ADPKD: case-control study
Valentina Corradi et al.
CLINICAL NEPHROLOGY (2016)
Factors associated with patient recall of individualized dietary recommendations for kidney stone prevention
K. L. Penniston et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2016)
Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease
Amali C. Mallawaarachchi et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Commentary: Accepting what we don't know will lead to progress
Martin O'Donnell et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates Proteinuria
Hao Yu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Proteomics of Urinary Vesicles Links Plakins and Complement to Polycystic Kidney Disease
Mandi Salih et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Sodium and cardiovascular disease Reply
Andrew Mente et al.
LANCET (2016)
The importance of total kidney volume in evaluating progression of polycystic kidney disease
Jared J. Grantham et al.
NATURE REVIEWS NEPHROLOGY (2016)
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
Ron T. Gansevoort et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Dietary Sodium and Cardiovascular Disease Risk
NEW ENGLAND JOURNAL OF MEDICINE (2016)
ACE inhibitors, left ventricular mass and renal cyst growth in ADPKD
Robert W. Schrier
PHARMACOLOGICAL RESEARCH (2016)
Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-β1 in Autosomal Dominant Polycystic Kidney Disease Patients
Derya Kocer et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2016)
Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study
Tatsuya Suwabe et al.
BMC NEPHROLOGY (2016)
North American experience with Low protein diet for Non-dialysis-dependent chronic kidney disease
Kamyar Kalantar-Zadeh et al.
BMC NEPHROLOGY (2016)
WHO analgesic ladder: a good concept gone astray
Jane C. Ballantyne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
WHO analgesic ladder: a good concept gone astray
Jane C. Ballantyne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Phenomics
Matthew B. Lanktree et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease
Marie Neuville et al.
PLOS ONE (2016)
Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System
Moritoshi Kinoshita et al.
PLOS ONE (2016)
International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst Infection
Marten A. Lantinga et al.
NEPHRON (2016)
Co-existing autosomal dominant polycystic kidney disease and nephrotic syndrome in a Nigerian patient with lupus nephritis
A. A. Akinbodewa et al.
ANNALS OF AFRICAN MEDICINE (2016)
Estimation of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease
Edwin M. Spithoven et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function
Wendy E. Boertien et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis?
Niek F. Casteleijn et al.
AMERICAN JOURNAL OF NEPHROLOGY (2015)
Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD)
Akiko Nakajima et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2015)
Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan
Laura R. Harskamp et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
18F-FDG PET/CT during diagnosis and follow-up of recurrent hepatic cyst infection in autosomal dominant polycystic kidney disease
Marten A. Lantinga et al.
CLINICAL NEPHROLOGY (2015)
Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics
T. Suwabe et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Management of Pain in Autosomal Dominant Polycystic Kidney Disease and Anatomy of Renal Innervation
Matthew W. Tellman et al.
JOURNAL OF UROLOGY (2015)
Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease
Elaine Ku et al.
KIDNEY INTERNATIONAL (2015)
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Arlene B. Chapman et al.
KIDNEY INTERNATIONAL (2015)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Renal Stone Disease
Andrew Mallett et al.
SEMINARS IN NEPHROLOGY (2015)
Identification of Biomarkers for PKD1 Using Urinary Exosomes
Marie C. Hogan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials
Maria V. Irazabal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease
Wouter N. Leonhard et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Diagnostic criteria in renal and hepatic cyst infection
Marten A. Lantinga et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Rationale for early treatment of polycystic kidney disease
Jared J. Grantham
PEDIATRIC NEPHROLOGY (2015)
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data
Tyler Knight et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2015)
Pheochromocytoma as a rare cause of arterial hypertension in a patient with autosomal dominant polycystic kidney disease: A diagnostic and therapeutic dilemma
Amelia J. Hessheimer et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2015)
Compared With Usual Sodium Intake, Low- and Excessive-Sodium Diets Are Associated With Increased Mortality: A Meta-Analysis
Niels Graudal et al.
AMERICAN JOURNAL OF HYPERTENSION (2014)
ESRD From Autosomal Dominant Polycystic Kidney Disease in the United States, 2001-2010
Scott Reule et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Health-Related Quality of Life in Patients With Autosomal Dominant Polycystic Kidney Disease and CKD Stages 1-4: A Cross-sectional Study
Dana C. Miskulin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease
Esther Meijer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Chronic Kidney Pain in Autosomal Dominant Polycystic Kidney Disease: A Case Report of Successful Treatment by Catheter-Based Renal Denervation
Niek F. Casteleijn et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
Debbie Zittema et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Effect of Pravastatin on Total Kidney Volume, Left Ventricular Mass Index, and Microalbuminuria in Pediatric Autosomal Dominant Polycystic Kidney Disease
Melissa A. Cadnapaphornchai et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Low-Dose Rapamycin ( Sirolimus) Effects in Autosomal Dominant Polycystic Kidney Disease: An Open-Label Randomized Controlled Pilot Study
William E. Braun et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Genetics and Pathogenesis of Autosomal Dominant Polycystic Kidney Disease: 20 Years On
Emilie Cornec-Le Gall et al.
HUMAN MUTATION (2014)
Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease
Peter C. Harris et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Predictors of Autosomal Dominant Polycystic Kidney Disease Progression
Robert W. Schrier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Treatments to slow progression of autosomal dominant polycystic kidney disease: systematic review and meta-analysis of randomized trials
Thida M. Myint et al.
NEPHROLOGY (2014)
A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease
Niek F. Casteleijn et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?
Eiji Higashihara et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry
Edwin M. Spithoven et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease
Frederic Rahbari-Oskoui et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
Robert W. Schrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Controlled Trial of Renal Denervation for Resistant Hypertension
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Relationship of Copeptin, a Surrogate Marker for Arginine Vasopressin, With Change in Total Kidney Volume and GFR Decline in Autosomal Dominant Polycystic Kidney Disease: Results From the CRISP Cohort
Wendy E. Boertien et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Medical Management to Prevent Recurrent Nephrolithiasis in Adults: A Systematic Review for an American College of Physicians Clinical Guideline
Howard A. Fink et al.
ANNALS OF INTERNAL MEDICINE (2013)
Surgical Cyst Decortication in Autosomal Dominant Polycystic Kidney Disease
Melissa Millar et al.
JOURNAL OF ENDOUROLOGY (2013)
Type of PKD1 Mutation Influences Renal Outcome in ADPKD
Emilie Cornec-Le Gall et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The medicinal use of water in renal disease
Connie J. Wang et al.
KIDNEY INTERNATIONAL (2013)
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
Anna Caroli et al.
LANCET (2013)
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
Isaline Rowe et al.
NATURE MEDICINE (2013)
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study
Ivana Pavik et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease
Imed Helal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Serum Uric Acid Levels and Endothelial Dysfunction in Patients with Autosomal Dominant Polycystic Kidney Disease
Ismail Kocyigit et al.
NEPHRON CLINICAL PRACTICE (2013)
Urinary Proteomic Biomarkers for Diagnosis and Risk Stratification of Autosomal Dominant Polycystic Kidney Disease: A Multicentric Study
Andreas D. Kistler et al.
PLOS ONE (2013)
Apelin and copeptin: Two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease
Antonio Lacquaniti et al.
PEPTIDES (2013)
Cardiovascular Complications in Autosomal Dominant Polycystic Kidney Disease
Tevfik Ecder
CURRENT HYPERTENSION REVIEWS (2013)
Management of Chronic Pain in a Patient With Autosomal Dominant Polycystic Kidney Disease by Sequential Celiac Plexus Blockade, Radiofrequency Ablation, and Spinal Cord Stimulation
Nathaniel Walsh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria
Tatsuya Suwabe et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Soluble Klotho and Autosomal Dominant Polycystic Kidney Disease
Ivana Pavik et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy
M. Losekoot et al.
JOURNAL OF MEDICAL GENETICS (2012)
Sodium Intake, ACE Inhibition, and Progression to ESRD
Stefan Vegter et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Dose-Dependent Effects of Sirolimus on mTOR Signaling and Polycystic Kidney Disease
Zlata Novalic et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Long-Term Impact of Laparoscopic Cyst Decortication on Renal Function, Hypertension and Pain Control in Patients with Autosomal Dominant Polycystic Kidney Disease
Mohammed Haseebuddin et al.
JOURNAL OF UROLOGY (2012)
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers
Hiddo J. Lambers Heerspink et al.
KIDNEY INTERNATIONAL (2012)
Analysis of baseline parameters in the HALT polycystic kidney disease trials
Vicente E. Torres et al.
KIDNEY INTERNATIONAL (2012)
Evaluation of urine biomarkers of kidney injury in polycystic kidney disease
Chirag R. Parikh et al.
KIDNEY INTERNATIONAL (2012)
Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease
Wendy E. Boertien et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study
Giovanni Stallone et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Somatostatin analog therapy for severe polycystic liver disease: results after 2 years
Marie C. Hogan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hypertension and Autosomal Dominant Polycystic Kidney Disease
Robert W. Schrier
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Water Prescription in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study
Connie J. Wang et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease
Esther Meijer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes
Merlin C. Thomas et al.
DIABETES CARE (2011)
Mutations in Multiple PKD Genes May Explain Early and Severe Polycystic Kidney Disease
Carsten Bergmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
A case of primary aldosteronism revealed after renal transplantation
Ewout J. Hoorn et al.
NATURE REVIEWS NEPHROLOGY (2011)
Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and cystic kidneys. a case series
Giorgina B. Piccoli et al.
BMC NEPHROLOGY (2011)
Evaluation and Management of Pain in Autosomal Dominant Polycystic Kidney Disease
Marie C. Hogan et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2010)
Hypertension in Autosomal Dominant Polycystic Kidney Disease
Arlene B. Chapman et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2010)
Association of Urinary Biomarkers With Disease Severity in Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-sectional Analysis
Esther Meijer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
A Review of the Thoracic Splanchnic Nerves and Celiac Ganglia
Marios Loukas et al.
CLINICAL ANATOMY (2010)
A Pilot Clinical Study to Evaluate Changes in Urine Osmolality and Urine cAMP in Response to Acute and Chronic Water Loading in Autosomal Dominant Polycystic Kidney Disease
Irina Barash et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease
Marie C. Hogan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Sirolimus Therapy to Halt the Progression of ADPKD
Norberto Perico et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Percutaneous Nephrolithotomy for Large or Multiple Upper Tract Calculi and Autosomal Dominant Polycystic Kidney Disease
Eric C. Umbreit et al.
JOURNAL OF UROLOGY (2010)
Phenomics: the next challenge
David Houle et al.
NATURE REVIEWS GENETICS (2010)
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Lawrence J. Appel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
Andreas L. Serra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Gerd Walz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease
Robert G. Fassett et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2010)
Evaluation of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Patients
Jose L. Nishiura et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
A Case for Water in the Treatment of Polycystic Kidney Disease
Vicente E. Torres et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Lanreotide reduces the volume of polycystic liver: A randomized, double-blind, placebo-controlled trial
Loes Van Keimpema et al.
GASTROENTEROLOGY (2009)
Renal injury is a third hit promoting rapid development of adult polycystic kidney disease
Ayumi Takakura et al.
HUMAN MOLECULAR GENETICS (2009)
Unified Criteria for Ultrasonographic Diagnosis of ADPKD
York Pei et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Family History of Renal Disease Severity Predicts the Mutated Gene in ADPKD
Moumita Barua et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease
Sandro Rossetti et al.
KIDNEY INTERNATIONAL (2009)
Vasopressin directly regulates cyst growth in polycystic kidney disease
Xiaofang Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Determinants of renal volume in autosomal-dominant polycystic kidney disease
J. J. Grantham et al.
KIDNEY INTERNATIONAL (2008)
Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease
Raoul Zeltner et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
A dietary quality comparison of popular weight-loss plans
Yunsheng MA et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2007)
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)
Nancy R. Cook et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease
Sule Namli et al.
RENAL FAILURE (2007)
Effect of dietary protein restriction on the progression of kidney disease: Long-term follow-up of the Modification of Diet in Renal Disease (MDRD) study
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Volume progression in polycystic kidney disease
JJ Grantham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes
Jared J. Grantham et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease
P Ruggenenti et al.
KIDNEY INTERNATIONAL (2005)
[Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells -: Relevance to the ADPKD phenotype
SN Kip et al.
CIRCULATION RESEARCH (2005)
Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease
K Nutahara et al.
NEPHRON CLINICAL PRACTICE (2005)
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease
IS Lantinga-van Leeuwen et al.
HUMAN MOLECULAR GENETICS (2004)
Thoracoscopic renal denervation for intractable autosomal dominant polycystic kidney disease-related pain
O Chapuis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort
AB Chapman et al.
KIDNEY INTERNATIONAL (2003)
No effect of enalapril on progression in autosomal dominant polycystic kidney disease
MA van Dijk et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein
CJ Ward et al.
NATURE GENETICS (2002)
Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease
MA van Dijk et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease
T Ecder et al.
AMERICAN JOURNAL OF NEPHROLOGY (2001)
Laparoscopic renal denervation for intractable ADPKD-related pain
JF Valente et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease
SA Grampsas et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Share Paper
